Product Information

ARNUITY ELLIPTA 100 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $6.6520 per EA under NDC 00173087414. Its NADAC has been published 135 times since Apr 17, 2024.

FDA first approved this application on Aug 20, 2014.

ARNUITY ELLIPTA 100 MCG INH

fluticasone furoate
$6.6520per EA

Strength

100 ug/1

NDC

00173087414

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Effective Date

10/21/2026

Active Ingredients

FLUTICASONE FUROATE

Approval Type

New Drug (NDA)

FDA Application

NDA205625

FDA Approved

8/20/2014

On Market Since

8/20/2014

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for ARNUITY ELLIPTA 100 MCG INH has been published 135 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$6.6520 per EA
All-time high$6.6932 (Aug 13, 2025)
All-time low$6.6349 (Sep 18, 2024)
52-week high$6.6862
52-week low$6.6476
Median price$6.6688
Average price$6.6671
Largest weekly change+0.4% (Jul 23, 2025)
Weeks tracked135
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.5%

3Y

N/A

5Y

N/A

All

+0.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ARNUITY ELLIPTA 100 MCG INH?

The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 100 MCG INH, manufactured by GlaxoSmithKline LLC, is $6.6520 per EA (NDC 00173087414), effective Nov 11, 2026.

How has the price of ARNUITY ELLIPTA 100 MCG INH changed over time?

Over the history we have for it, the NADAC for ARNUITY ELLIPTA 100 MCG INH has held within roughly two percent of its current level. It has been tracked across 135 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 100 MCG INH?

Since Apr 17, 2024, the NADAC for ARNUITY ELLIPTA 100 MCG INH has ranged from a low of $6.6349 (Sep 18, 2024) to a high of $6.6932 (Aug 13, 2025), with a median of $6.6688 per EA.

Are there cheaper alternatives to ARNUITY ELLIPTA 100 MCG INH?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 100 MCG INH, is $4.2928 per EA — about 35% below ARNUITY ELLIPTA 100 MCG INH.

Who manufactures ARNUITY ELLIPTA 100 MCG INH?

ARNUITY ELLIPTA 100 MCG INH (NDC 00173087414) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.